Breaking News, Collaborations & Alliances

Kindeva Drug Delivery, Emervax Partner on Vaccine Administration

Combining Emervax’s emxRNA with Kindeva’s microneedle patch technology aims to allow for ease of transport and administration of vaccines.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Image: Kindeva Drug Delivery

Kindeva Drug Delivery, a global CDMO, and Emervax, developer of a circular RNA-based vaccine platform (emxRNA), entered an exclusive partnership to co-develop an innovative solution for the administration of vaccines targeting a variety of emerging viruses. Kindeva has granted Emervax an exclusive license to use its solid-coated microneedle array patch for their next-gen emxRNA platform for RNA vaccines. Kindeva’s technology combined with Emervax’s emxRNA platform aims to set a new standard f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters